China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
0.0410
-0.0070 (-14.58%)
At close: Oct 23, 2026, 4:00 PM EDT
0.0393
-0.0017 (-4.15%)
After-hours: Oct 23, 2026, 7:49 PM EDT
China SXT Pharmaceuticals Revenue
In the fiscal year ending March 31, 2026, China SXT Pharmaceuticals had annual revenue of $1.14M, down -34.63%. China SXT Pharmaceuticals had revenue of $511.48K in the half year ending March 31, 2026, a decrease of -48.28%. That makes China SXT Pharmaceuticals the 43,369th largest company in the world by revenue and 6,037th in the United States.
Revenue (ttm)
$1.14M
Revenue Growth
-34.63%
P/S Ratio
0.05
Revenue / Employee
$20,322
Employees
56
Market Cap
54.18K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.14M | -602.86K | -34.63% |
| Mar 31, 2025 | 1.74M | -187.59K | -9.73% |
| Mar 31, 2024 | 1.93M | -43.18K | -2.19% |
| Mar 31, 2023 | 1.97M | -630.60K | -24.23% |
| Mar 31, 2022 | 2.60M | -2.18M | -45.53% |
| Mar 31, 2021 | 4.78M | -384.70K | -7.45% |
| Mar 31, 2020 | 5.16M | -1.85M | -26.38% |
| Mar 31, 2019 | 7.01M | -7.22K | -0.10% |
| Mar 31, 2018 | 7.02M | 2.14M | 43.79% |
| Mar 31, 2017 | 4.88M | 1.16M | 31.27% |
| Mar 31, 2016 | 3.72M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sunshine Biopharma | 35.35M |
| IM Cannabis | 32.25M |
| Sonoma Pharmaceuticals | 21.92M |
| cbdMD | 20.93M |
| InMed Pharmaceuticals | 4.94M |
| Akanda | 662.47K |
| Gelteq | 314.70K |
| RedHill Biopharma | 286.00K |
SXTC News
- 21 hours ago - China SXT Pharmaceuticals Inc trading halted, news pending - TheFly
- 2 days ago - China SXT Pharmaceuticals implementing 1-for-100 share consolidation - TheFly
- 2 days ago - China SXT Pharmaceuticals, Inc. Announces Share Consolidation - PRNewsWire
- 3 days ago - China SXT Pharmaceuticals announces termination of additional purchase right - TheFly
- 3 days ago - China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right - PRNewsWire
- 16 days ago - China SXT Pharmaceuticals announces $12M registered direct offering - TheFly
- 16 days ago - 3 Penny Stocks to Watch Today, October 8 - TipRanks
- 16 days ago - China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering - PRNewsWire